Monovisc Generic Name & Formulations
Sodium hyaluronate 22mg/mL; viscoelastic soln for intra-articular inj.
Single-use syringe (4mL)—1
Treatment of pain in osteoarthritis of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy or simple analgesics (eg, acetaminophen).
Monovisc Dosage and Administration
Remove synovial fluid or effusion before inj. Give as a single intra-articular inj. 4mL in one knee only. If bilateral treatment: use one syringe in each knee.
≤21yrs: not established.
Gram (+) bacterial protein allergy. Infections or skin diseases in area of inj site/joint. Systemic bleeding disorders.
Monovisc Boxed Warnings
Avoid strenuous or prolonged weight-bearing activities within 48hrs following inj. Pregnancy, nursing mothers: not established.
Avoid use of disinfectants containing quaternary ammonium salts; hyaluronan can precipitate in their presence.
Monovisc Adverse Reactions
Arthralgia, joint swelling, inj site pain.
Monovisc Clinical Trials
Monovisc Patient Counseling